Key Metrics
5.8
CiteScore
CiteScore
CiteScore measures average citations received per document published in the serial.
5 - 10
Impact Factor
Impact Factor
Impact factor of a journal is calculated by dividing the number of current year citations to the source items published in that journal during the previous two years.
0.9
5-Year SI
5-year SI
- 0.89 2-year SI
- 0.9 Lifetime SI
Scite Index
Scite Index
scite Index is the ratio of citations supporting research which is published in the journal to sum of citations either supporting or contrasting the research published in the journal for the same time period. Minimum 100 supporting citations required.
1.27
SNIP
SNIP
Source Normalized Impact per Paper measures actual citations received relative to citations expected for the serial’s subject field.
1 Mo
Time to Publish
Time to Publish
Based on turnaround time from submission to publication for papers (articles & reviews) published in 2022 and for journals with a sample of more than 10 papers.
Time To Publish
Time to Publish
Based on turnaround time from submission to publication for papers (articles & reviews) published in 2022 and for journals with a sample of more than 10 papers.
Time to Publish
Based on turnaround time from submission to publication for papers (articles & reviews) published in 2022 and for journals with a sample of more than 10 papers.
% of papers by time taken from submission to publication
0 to 3 months
96%
4 to 6 months
4%
7 to 9 months
0%
Above 9 months
0%
Did you find this useful?
Thank you for your feedback.
Indexed in the following public directories
-
Web of Science -
Scopus -
DOAJ -
SJR
Topics Covered
- Cancer
- Extracellular matrix
- Overall survival
- Carcinogenesis
- Lung cancer
- Lymphoma
- Neuroendocrine tumors
- Extracellular vesicles
- Nuclear magnetic resonance
- Meningioma
- Toxicity
- Immunotherapy
- Progression-free survival
- Positron emission tomography
- Hepatocellular carcinoma
- Breast cancer
- Machine learning
- Lung
- Oxidative stress
- Head and neck
Journal Specifications
| Overview | |
| Publisher | MDPI |
| Language | English |
| Frequency | Semi-monthly |
| Article Processing Charges | CHF 2600 |
| Publication Time | 6 |
| Editorial Review Process | Anonymous peer review |
| General Details | |
| Language | English |
| Frequency | Semi-monthly |
| Publication Start Year | 2009 |
| Publisher URL | Visit website |
| Website URL | Visit website |
| Publication Details | |
| Plagiarism | Visit website |
| Waiver Policy | Visit website |
| Publication Time | 6 |
| Article Processing Charges | CHF 2600 |
| Editorial Review Detail | |
| Editorial Team | Visit website |
| Review Process | Anonymous peer review |
| Review Url | Visit website |
| Information for authors | |
| Author instructions | Visit website |
| Copyright Details | Visit website |
| Deposit Policy | Sherpa/Romeo |
| License type | CC BY |
| OA statement | Visit website |
Planning to publish in Cancers ?
Upload your Manuscript to get
- Degree of match
- Common matching concepts
- Additional journal recommendations
Looking for the right journals to submit your mansucript?
Upload your manuscript and get a submission readiness score and other journal recommendations.
Check my PaperRecently Published Papers
-
Full paper
The Immune–Genomics of Cholangiocarcinoma: A Biological Footprint to Develop Novel Immunotherapies
- 15 Jan 25
- Cancers
-
Full paper
Necroptosis-Related Gene Signature Predicts Prognosis in Patients with Advanced Ovarian Cancer
- 15 Jan 25
- Cancers
-
Full paper
Resection and Reconstruction for Lung and Airway Tumors Invading the Carina
- 15 Jan 25
- Cancers
-
Full paper
Chimeric Antigen Receptor-T Cells in the Modern Era of Chronic Lymphocytic Leukemia Treatment
- 15 Jan 25
- Cancers
-
Full paper
Prevention and Treatment of Venous Thromboembolism Associated with Amivantamab-Based Therapies in Patients with Lung Cancer—Provisional Clinical Opinion Based on Existing Clinical Practice Guidelines
- 14 Jan 25
- Cancers
-
Full paper
Neoadjuvant Accelerated Methotrexate, Vinblastine, Doxorubicin, and Cisplatin Chemotherapy for Muscle-Invasive Urothelial Cancer: Large, Single-Center Analysis of Consecutive Patients’ Data
- 14 Jan 25
- Cancers
Scite analysis
Powered by scite_
29.4k articles received 356.4k citations see all
- 10,387 Supporting
- 340,899 Mentioning
- 1,098 Contrasting
Editorial notices
- 6 Retractions
- 0 Withdrawals
- 109 Corrections
- 83 Errata
- 0 Expression of Concern
FAQs
How long has Cancers been actively publishing?
Cancers has been in operation since 2009 till date.
What is the publishing frequency of Cancers ?
Cancers published with a Semi-monthly frequency.
How many articles did Cancers publish last years ?
In 2024, Cancers published 4190 articles.
What is the eISSN & pISSN for Cancers ?
For Cancers,eISSN is 2072-6694 and pISSN is2072-6694.
What is Citescore for Cancers ?
Citescore for Cancers is 5.8.
What is SNIP score for Cancers ?
SNIP score for Cancers is 1.27.
Who is the publisher of Cancers ?
MDPI is the publisher of Cancers.